Authors: Tanswell, P Garin-Chesa, P Rettig, WJ Welt, S Divgi, CR Casper, ES Finn, RD Larson, SM Old, LJ Scott, AM

Citation: P. Tanswell et al., Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients, BR J CL PH, 51(2), 2001, pp. 177-180

Authors: Burt, ME Liu, D Abolhoda, A Ross, HM Kaneda, Y Jara, E Casper, ES Ginsberg, RJ Brennan, MF

Citation: Me. Burt et al., Isolated lung perfusion for patients with unresectable metastases from sarcoma: A Phase I trial, ANN THORAC, 69(5), 2000, pp. 1542-1549

Authors: Flombaum, CD Mouradian, JA Casper, ES Erlandson, RA Benedetti, F

Citation: Cd. Flombaum et al., Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine, AM J KIDNEY, 33(3), 1999, pp. 555-562

Authors: Fata, F O'Reilly, E Ilson, D Pfister, D Leffel, D Kelsen, DP Schwartz, GK Casper, ES

Citation: F. Fata et al., Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face, CANCER, 86(10), 1999, pp. 2034-2037

Authors: Billingsley, KG Lewis, JJ Leung, DHY Casper, ES Woodruff, JM Brennan, MF

Citation: Kg. Billingsley et al., Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma, CANCER, 85(2), 1999, pp. 389-395

Authors: Lewis, JJ Leung, D Casper, ES Woodruff, J Hajdu, SI Brennan, MF

Citation: Jj. Lewis et al., Multifactorial analysis of long-term follow-up (more than 5 years) of primary extremity sarcoma, ARCH SURG, 134(2), 1999, pp. 190-194